Your browser doesn't support javascript.
loading
BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
Liu, Yang; Liu, Jianying; Xia, Hongjie; Zhang, Xianwen; Zou, Jing; Fontes-Garfias, Camila R; Weaver, Scott C; Swanson, Kena A; Cai, Hui; Sarkar, Ritu; Chen, Wei; Cutler, Mark; Cooper, David; Muik, Alexander; Sahin, Ugur; Jansen, Kathrin U; Xie, Xuping; Dormitzer, Philip R; Shi, Pei-Yong.
Afiliación
  • Liu Y; University of Texas Medical Branch, Galveston, TX.
  • Liu J; University of Texas Medical Branch, Galveston, TX.
  • Xia H; University of Texas Medical Branch, Galveston, TX.
  • Zhang X; University of Texas Medical Branch, Galveston, TX.
  • Zou J; University of Texas Medical Branch, Galveston, TX.
  • Fontes-Garfias CR; University of Texas Medical Branch, Galveston, TX.
  • Weaver SC; University of Texas Medical Branch, Galveston, TX.
  • Swanson KA; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Cai H; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Sarkar R; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Chen W; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Cutler M; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Cooper D; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Muik A; BioNTech, Mainz, Germany.
  • Sahin U; BioNTech, Mainz, Germany.
  • Jansen KU; Pfizer Vaccine Research and Development, Pearl River, NY.
  • Xie X; University of Texas Medical Branch, Galveston, TX xuxie@utmb.edu.
  • Dormitzer PR; Pfizer Vaccine Research and Development, Pearl River, NY philip.dormitzer@pfizer.com.
  • Shi PY; University of Texas Medical Branch, Galveston, TX peshi@utmb.edu.
N Engl J Med ; 385(5): 472-474, 2021 07 29.
Article en En | MEDLINE | ID: mdl-33979486
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: N Engl J Med Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticuerpos Neutralizantes / Inmunogenicidad Vacunal / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: N Engl J Med Año: 2021 Tipo del documento: Article